Hereditary angioedema in a Jordanian family with a novel missense mutation in the C1-inhibitor N-terminal domain. (March 2016)

• Record Type: Journal Article
• Authors: Jaradat, Saied A; Caccia, Sonia; Rawashdeh, Rifaat; Melhem, Motasem; Al-Hawamdeh, Ali; Carzaniga, Thomas; Haddad, Hazem
• Is Part Of: Molecular immunology. Volume 71(2016:Mar.)
• Page Start: 123
• Page End: 130
• Publication Date: 2016-03
• Subjects: C1-inhibitor -- SERPING1 gene -- Hereditary angioedema -- Jordan -- N-terminal domain; Immunochemistry -- Periodicals; Molecular biology -- Periodicals; Immunochemistry -- Periodicals; Allergy and Immunology -- Periodicals; Molecular Biology -- Periodicals; Immunochimie -- Périodiques; Biologie moléculaire -- Périodiques; Immunochemistry; Molecular biology; Periodicals; Electronic journals; 571.96
• DOI: 10.1016/j.molimm.2016.02.001
• Languages: English
• ISSNs: 0161-5890

Abstract

Highlights: We examined mutations in large Jordanian family with hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE). This is the first report of mutations in Jordanian family with HAE. Four different genetic variations in the SERPING1 gene were identified. Two of the variations are novel at the N- and C-terminal domains of the C1-INH. We provide family-based evidence that links a genetic variant in the N-terminal domain of the C1-inhibitor to HAE. Abstract: Hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) is an autosomal dominant disease caused by mutations in the SERPING1 gene. A Jordanian family, including 14 individuals with C1-INH-HAE clinical symptoms, was studied. In the propositus and his parents, SERPING1 had four mutations leading to amino acid substitutions. Two are known polymorphic variants (c.167T>C; p.Val34Ala and c.1438G>A; p.Val458Met), the others are newly described. One (c.203C>T; p.Thr46Ile) is located in the N-terminal domain of the C1-inhibitor protein and segregates with angioedema symptoms in the family. The other (c.800C>T; p.Ala245Val) belongs to the serpin domain, and derives from the unaffected father. DNA from additional 24 family members were screened for c.203C>T mutation in the target gene. All individuals heterozygous for the c.203C>T mutation had antigenic and functional plasma levels of C1-inhibitor below 50% of normal, confirming the diagnosis of type I C1-INH-HAE. Angioedema symptoms were present in 14 of 16 subjects carrier for the c.203T allele. Among these subjects, those carrying the c.800T variation had more severe and frequent symptoms than subjects without this mutation. This family-based study provides the first evidence that multiple amino acid substitutions in SERPING1 could influence C1-INH-HAE phenotype.